Arguello-Tomas, M, Albiol, N, Moreno, C. Frontline therapy in Chronic Lymphocytic Leukemia. ACTA HAEMATOLOGICA. 2023; 147(1)DOI:10.1159/000534730. PMID:37899041. IF:1.700(Q3/8D).

Socié G., Barba P., Barlev A., Sanz J., García-Cadenas I., Chevallier P., Fagioli F., Guzman-Becerra N., Kumar D., Ljungman P., Pigneux A., Sadetsky N., Yáñez San Segundo L., Shadman M., Storek J., Thirumalai D., Xing B., Mohty M.. Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. BONE MARROW TRANSPLANTATION. 2023; 59(1)DOI:10.1038/s41409-023-02127-9. PMID:37865719. IF:4.500(Q1/2D).

Piñana, JL, Heras, I, Aiello, TF, García-Cadenas, I, Vazquez, L, Lopez-Jimenez, J, Chorao, P, Aroca, C, García-Vidal, C, Arroyo, I, Soler-Espejo, E, López-Corral, L, Avendaño-Pita, A, Arrufat, A, Garcia-Gutierrez, V, Arellano, E, Hernández-Medina, L, González-Santillana, C, Morell, J, Hernández-Rivas, JA, Rodriguez-Galvez, P, Mico-Cerdá, M, Guerreiro, M, Campos, D, Navarro, D, Cedillo, A, Martino, R, Solano, C. Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Viruses-Basel. 2023; 15(10)DOI:10.3390/v15102066. PMID:37896843. IF:3.800(Q2/5D).

Albiol, N, Lynton-Pons, E, Aso, O, Moga, E, Vidal, S, Gomez-Perez, L, Santiago, JA, Triquell, M, Roch, N, Lazaro, E, Gonzalez, I, Lopez-Contreras, J, Esquirol, A, Sierra, J, Martino, R, Garcia-Cadenas, I. mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect. LEUKEMIA RESEARCH. 2023; 132DOI:10.1016/j.leukres.2023.107347. PMID:37356281. IF:2.100(Q3/6D).

Pinana, JL, Perez, A, Chorao, P, Guerreiro, M, Garcia-Cadenas, I, Solano, C, Martino, R, Navarro, D. Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances. Transplant Infectious Disease. 2023; DOI:10.1111/tid.14117. PMID:37585370. IF:2.600(Q2/5D).

Woyach, JA, Ghia, P, Byrd, JC, Ahn, IE, Moreno, C, O'Brien, SM, Jones, D, Cheung, LWK, Chong, ELZB, Kwei, K, Dean, JP, James, DF, Wiestner, A. B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy. CLINICAL CANCER RESEARCH. 2023; 29(16)DOI:10.1158/1078-0432.CCR-22-3887. PMID:37314786. IF:10.400(Q1/1D).

Fernandez-Sojo J., Valdivia E., Esquirol A., Portos, JM, Rovira M., Suarez M., Diaz-de-Heredia C., Uria, ML, Ortí G., Ferra C., Mussetti A., Paviglianiti A., Marsal J., Badell I., Lozano M., Gomez D., Azqueta C., Martorell L., Rubio N., Garcia-Buendia A., Villa J., Carreras E., Querol S.. Development of an in-house bone marrow collection kit: The Catalan bone marrow transplantation group experience. VOX SANGUINIS. 2023; 118(9)DOI:10.1111/vox.13499. PMID:37533171. IF:1.800(Q3/7D).

Munir, T, Moreno, C, Owen, C, Follows, G, Benjamini, O, Janssens, A, Levin, MD, Osterborg, A, Robak, T, Simkovic, M, Stevens, D, Voloshin, S, Vorobyev, V, Yagci, M, Ysebaert, L, Qi, KQ, Qi, QY, Parisi, L, Srinivasan, S, Schuier, N, Baeten, K, Howes, A, Caces, DB, Niemann, CU, Kater, AP. Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study. JOURNAL OF CLINICAL ONCOLOGY. 2023; 41(21)DOI:10.1200/JCO.22.02283. PMID:37279408. IF:42.100(Q1/1D).

Arguello-Tomas M., Albiol N., Jara P., Garcia-Cadenas I., Redondo S., Esquirol A., Novelli S., Saavedra S., Martino R., Nomdedeu J., Sierra J., Mora A., Moreno C.. Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center. LEUKEMIA & LYMPHOMA. 2023; 64(10)DOI:10.1080/10428194.2023.2232489. PMID:37452739. IF:2.200(Q3/6D).

Berengua, C, Miro, E, Gutierrez, C, Sanchez, M, Mulero, A, Ramos, P, del Cuerpo, M, Torrego, A, Garcia-Cadenas, I, Pajares, V, Navarro, F, Martino, R, Rabella, N. Detection of cytomegalovirus in bronchoalveolar lavage fluid from immunocompromised patients with pneumonitis by viral culture and DNA quantification. JOURNAL OF VIROLOGICAL METHODS. 2023; 317DOI:10.1016/j.jviromet.2023.114743. PMID:37116585. IF:2.200(Q3/7D).

Garcia-Cadenas, I, Redondo, S, Esquirol, A, Portos, JM, Novelli, S, Saavedra, S, Moreno, C, Garrido, A, Onate, G, Lopez, J, Caballero, AC, Miqueleiz, S, Arguello-Tomas, M, Briones, J, Sierra, J, Martino, R. Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature. Transplantation And Cellular Therapy. 2023; 29(7)DOI:10.1016/j.jtct.2023.04.008. PMID:37086849. IF:3.600(Q1/3D).

Coll, CF, de la Fe, MM, Garcia, LP, Vaz, CP, Fernando, MIH, Almorox, RB, Garcia-Cadenas, I, Munoz, MC, Ripa, TZ, Al-Sibai, JZ, Novoa, S, Aguado, B, Catarineu, AT, Lopez-Godino, O, Bofarull, RM, Kwon, M, Campos, A, Barrigon, DC, Santasusana, JMR. Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; 110(6)DOI:10.1111/ejh.13947. PMID:36813736. IF:2.300(Q2/5D).

Onate, G, Pratcorona M., Garrido A., Artigas-Baleri A., Bataller A., Tormo M., Arnan M., Vives S., Coll R., Salamero O., Vall-Llovera F., Sampol A., Garcia A., Cervera M., Avila S.G., Bargay J., Ortín X., Nomdedéu J.F., Esteve J., Sierra J.. Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort. Blood Cancer Journal. 2023; 13(1)DOI:10.1038/s41408-023-00839-1. PMID:37147301. IF:12.900(Q1/1D).

Pinana, JL, Martino, R, Vazquez, L, Lopez-Corral, L, Perez, A, Chorao, P, Avendano-Pita, A, Pascual, MJ, Sanchez-Salinas, A, Sanz-Linares, G, Olave, MT, Arroyo, I, Tormo, M, Villalon, L, Conesa-Garcia, V, Gago, B, Terol, MJ, Villalba, M, Garcia-Gutierrez, V, Cabero, A, Hernandez-Rivas, JA, Ferrer, E, Garcia-Cadenas, I, Teruel, A, Navarro, D, Cedillo, A, Sureda, A, Solano, C. SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination. BONE MARROW TRANSPLANTATION. 2023; 58(5)DOI:10.1038/s41409-023-01946-0. PMID:36854892. IF:4.500(Q1/2D).

Velao, SR, Cadenas, IG, Cuesta, MA, Sanchez-Ortega, I, Fernandez-Aviles, F, Roldan, E, Torrent, A, Viguria, MC, Villar, S, Bento, L, Yanez, L, Martino, R, Pinana, JL. Low rate of infectious enterocolitis in allogeneic stem cell transplant recipients with acute diarrhea: A prospective study by the GETH-TC.. ACTA HAEMATOLOGICA. 2023; 146(2)DOI:10.1159/000528242. PMID:36446336. IF:1.700(Q3/8D).

Mussetti, A, Bento, L, Bastos-Oreiro, M, Rius-Sansalvador, B, Albo, C, Bailen, R, Barba, P, Benzaquen, A, Briones, J, Caballero, AC, Campos, A, Espanol, I, Ferra, C, Lopez, SG, Sierra, PAG, Guerra, LM, Hernani, R, Iacoboni, G, Jimenez-Ubieto, A, Kwon, M, Corral, LL, Lopez-Godino, O, Munoz, MCM, Martinez-Cibrian, N, Gomez, JM, Perez-Ortega, L, Orti, G, Ortiz-Maldonado, V, Pascual, MJ, Perera, M, Perez, A, Reguera, JL, Sanchez, JM, Sanz, J, Torrent, A, Yanez, L, Varela, R, Echechipia, IC, Caballero, D, Sureda, A. Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era (Mar, 10.1038/s41409-023-01949-x, 2023). BONE MARROW TRANSPLANTATION. 2023; 58(6)DOI:10.1038/s41409-023-01967-9. PMID:37076611. IF:4.500(Q1/2D).

Crees, ZD, Rettig, MP, Jayasinghe, RG, Stockerl-Goldstein, K, Larson, SM, Arpad, I, Milone, GA, Martino, M, Stiff, P, Sborov, D, Pereira, D, Micallef, I, Moreno-Jimenez, G, Mikala, G, Coronel, MLP, Holtick, U, Hiemenz, J, Qazilbash, MH, Hardy, N, Latif, T, Garcia-Cadenas, I, Vainstein-Haras, A, Sorani, E, Gliko-Kabir, I, Goldstein, I, Ickowicz, D, Shemesh-Darvish, L, Kadosh, S, Gao, F, Schroeder, MA, Vij, R, DiPersio, JF. Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial. NATURE MEDICINE. 2023; 29(4)DOI:10.1038/s41591-023-02273-z. PMID:37069359. IF:58.700(Q1/1D).

Perl A.E., Larson R.A., Podoltsev N.A., Strickland S., Wang E.S., Atallah E., Schiller G.J., Martinelli G., Neubauer A., Sierra J., Montesinos P., Recher C., Yoon S.-S., Maeda Y., Hosono N., Onozawa M., Kato T., Kim H.-J., Hasabou N., Nuthethi R., Tiu R., Levis M.J.. Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy. Transplantation And Cellular Therapy. 2023; 29(4)DOI:10.1016/j.jtct.2022.12.006. PMID:36526260. IF:3.600(Q1/3D).

Martin-Fernandez, L, Garcia-Martinez, I, Lopez, S, Martinez-Perez, A, Vilalta, N, Plaza, M, Moret, C, Vinuela, A, Brown, AA, Panousis, NI, Buil, A, Dermitzakis, ET, Corrales, I, Souto, JC, Vidal, F, Soria, JM. Multiallelic Copy Number Variation in ORM1 is Associated with Plasma Cell-Free DNA Levels as an Intermediate Phenotype for Venous Thromboembolism. THROMBOSIS AND HAEMOSTASIS. 2023; 123(04)DOI:10.1055/s-0043-1760844. PMID:36696913. IF:5.000(Q1/2D).

Mussetti, A, Bento, L, Bastos-Oreiro, M, Sansalvador, BR, Albo, C, Bailen, R, Barba, P, Benzaquen, A, Briones, J, Caballero, AC, Campos, A, Espanol, I, Ferra, C, Lopez, SG, Sierra, PAG, Guerra, LM, Hernani, R, Iacoboni, G, Ubieto, AIJ, Kwon, M, Corral, LL, Lopez-Godino, O, Munoz, MCM, Martinez-Cibrian, N, Gomez, JM, Perez-Ortega, L, Ortf, G, Ortiz-Maldonado, V, Pascual, MJ, Perera, M, Perez, A, Reguera, JL, Sanchez, JM, Sanz, J, Torrent, A, Yanez, L, Varela, R, Echechipia, IC, Caballero, D, Sureda, A. Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era. BONE MARROW TRANSPLANTATION. 2023; 58(6)DOI:10.1038/s41409-023-01949-x. PMID:36918682. IF:4.500(Q1/2D).